These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritis. Rivers JK; Podgorski MR; Goulding NJ; Wong E; McGrath JA; Flower RJ; Greaves MW Br J Dermatol; 1990 Nov; 123(5):569-72. PubMed ID: 2147389 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. Stevens TR; Smith SF; Rampton DS Clin Sci (Lond); 1993 Apr; 84(4):381-6. PubMed ID: 8097682 [TBL] [Abstract][Full Text] [Related]
7. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity. Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633 [TBL] [Abstract][Full Text] [Related]
8. High levels of antibodies to annexins V and VI in patients with rheumatoid arthritis. Dubois T; Bisagni-Faure A; Coste J; Mavoungou E; Menkes CJ; Russo-Marie F; Rothhut B J Rheumatol; 1995 Jul; 22(7):1230-4. PubMed ID: 7562750 [TBL] [Abstract][Full Text] [Related]
9. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen. Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213 [TBL] [Abstract][Full Text] [Related]
11. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR; Simpson DF; Hurley BL; Matsuura E Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [TBL] [Abstract][Full Text] [Related]
12. Corticosteroids increase lipocortin I in BAL fluid from normal individuals and patients with lung disease. Ambrose MP; Hunninghake GW J Appl Physiol (1985); 1990 Apr; 68(4):1668-71. PubMed ID: 2140829 [TBL] [Abstract][Full Text] [Related]
13. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis. Karsh J; Halbert SP; Anken M; Klima E; Steinberg AD Int Arch Allergy Appl Immunol; 1982; 68(1):60-9. PubMed ID: 6978853 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2. Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895 [TBL] [Abstract][Full Text] [Related]
15. IgG, IgA, and IgM antibodies to mite in sera and sputa from asthmatic patients. Kitani S; Ito K; Miyamoto T Ann Allergy; 1985 Oct; 55(4):612-20. PubMed ID: 3876792 [TBL] [Abstract][Full Text] [Related]
16. Altered immunoglobulin metabolism in systemic lupus erythematosus and heumatoid arthritis. Levy J; Barnett EV; MacDonald NS; Klinenberg JR J Clin Invest; 1970 Apr; 49(4):708-15. PubMed ID: 5309797 [TBL] [Abstract][Full Text] [Related]